Search - tctmd.com

Displaying 1 - 20 of 174

Sort: Relevancy | Date

News Daily News

Leaflet Thickening, Valve Durability After Balloon-Expandable TAVR: Studies Offer New Insights

Todd Neale

December 26, 2016

News Daily News

Women More Likely to be Alive 1 Year After TAVR: STS/ACC TVT Registry

Michael O'Riordan

December 19, 2016

News Daily News

Conduction Problems Requiring Permanent Pacemakers Continue to Vex TAVR Field

Todd Neale

November 08, 2016

News Conference News TCT 2016

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

Todd Neale

November 01, 2016

News Industry News

Boston Scientific Receives CE Mark For LOTUS Edge™ Valve System

September 19, 2016

News Daily News

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

Yael L. Maxwell

August 24, 2016

News Daily News

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

Yael L. Maxwell

August 18, 2016

News Daily News

CMR Confirms Link Between Moderate Aortic Regurgitation Post-TAVR and Poor Outcomes, Mortality

Yael L. Maxwell

August 05, 2016

News Daily News

Blood Test May Be Useful for Detecting Aortic Regurgitation During TAVR

L.A. McKeown

July 27, 2016

News Daily News

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

Michael O'Riordan

July 05, 2016

News Conference News TVT 2016

What TAVR Needs Next . . . and What It’s Getting

Shelley Wood

June 17, 2016

News Features

Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent

Caitlin E. Cox

June 17, 2016

News Daily News

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Shelley Wood

June 07, 2016

News Conference News EuroPCR 2016

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

Michael O'Riordan

May 23, 2016

News Conference News EuroPCR 2016

‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices

Caitlin E. Cox

May 17, 2016

News Daily News

Italian Registry Cautions Against TAVR in Low-Risk Patients

L.A. McKeown

May 16, 2016

News Conference News SCAI 2016

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

L.A. McKeown

May 11, 2016

News Conference News ACC 2016

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

L.A. McKeown

April 04, 2016

News Conference News ACC 2016

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

Yael L. Maxwell

April 03, 2016

News Conference News ACC 2016

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Shelley Wood

April 02, 2016

Advertisement

Leaflet Thickening, Valve Durability After Balloon-Expandable TAVR: Studies Offer New Insights

Women More Likely to be Alive 1 Year After TAVR: STS/ACC TVT Registry

Conduction Problems Requiring Permanent Pacemakers Continue to Vex TAVR Field

Midterm Durability of TAVR Valves: PARTNER, Other Studies Boost Confidence

Boston Scientific Receives CE Mark For LOTUS Edge™ Valve System

TAVR as an Option for Intermediate-Risk Patients: Physicians Respond

FDA Approves Sapien XT and Sapien 3 for Intermediate-Risk Patients

CMR Confirms Link Between Moderate Aortic Regurgitation Post-TAVR and Poor Outcomes, Mortality

Blood Test May Be Useful for Detecting Aortic Regurgitation During TAVR

TAVR for Bicuspid Aortic Valve Stenosis Feasible, but Associated With Higher Rate of Permanent Pacemaker Implantation

What TAVR Needs Next . . . and What It’s Getting

Digesting the Valve Degeneration Data: One Month Later, Reactions From TAVR Experts Range From ‘Disturbed’ to Indifferent

More Proof of Declining Paravalvular Regurgitation With Newest Balloon-Expandable TAVR Devices

Studies Highlight Permanent Pacemaker Rates Among New-Generation TAVR Devices

‘Signal’ of Poor Durability Seen With First-Generation TAVR Devices

Italian Registry Cautions Against TAVR in Low-Risk Patients

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

Self-Expanding Transcatheter Valve Maintains Advantage Over Surgery at 3 Years in High-Risk Elderly Patients

Sapien 3 Superior to Surgery Among Intermediate-Risk Patients in Observational Trial

TAVR With Sapien XT Noninferior to Surgery in Intermediate-Risk Patients, With a Win for Transfemoral

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content